Zhitong Finance App News, Shiyao Group (01093.HK) announced that the dopamine receptor agonist rotigotin long-term injection (SYH 9087 injection) developed by the Group has been approved by the China Drug Administration and can conduct clinical trials in China.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.